價(jià)格 | 詢價(jià) | |
包裝 | 10mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-02 |
中文名稱:化合物 Antitumor agent-138 | 英文名稱:Antitumor agent-138 |
CAS:2975168-22-8 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T85704 |
名稱 | Antitumor agent-138 |
描述 | Antitumor agent-138 (compound 5b), with an IC 50 of 1.87 μM, inhibits tubulin polymerization at the tubulin colchicine-binding sites. It arrests the cell cycle at the G2/M phase and induces apoptosis in MCF-7 cells. Additionally, this compound suppresses cell migration and angiogenesis [1]. |
體外活性 | Antitumor agent-138在細(xì)胞MCF-7, A549, MDA-MB-231, HT-29, HeLa和L02中表現(xiàn)出抗增殖活性,IC50值分別是0.04, 0.39, 0.04, 0.06, 0.11和2.73 μM [1]。Antitumor agent-138 (5-20 nM)抑制人乳腺癌細(xì)胞MCF-7集落的形成[1]。Antitumor agent-138 (25-200 nM)誘導(dǎo)MCF-7中微管蛋白崩潰[1]。Antitumor agent-138 (6.25-50 nM)劑量依賴地抑制HUVEC細(xì)胞成管,抑制血管形成[1]。Cell Migration Assay [1] Cell Line: A549 Concentration: 6.25-50 nM Incubation Time: 24 h Result: Inhibited the cell migration in a dose-dependent manner. Cell Proliferation Assay [1] Cell Line: MCF-7, A549, MDA-MB-231, HT-29, HeLa and L02 Concentration: 0-5 μM Incubation Time: 48 h Result: Exhibited anti-proliferative properties in cancer cells MCF-7, A549, MDA-MB-231, HT-29, HeLa with low concentrations in nanomole. Western Blot Analysis [1] Cell Line: MCF-7 Concentration: 6.25-25 nM Incubation Time: 24 h Result: Increased P21, Cyclin B1, Cdc25c and cdk7 in a dose- and time-dependent manner. Increased Bax, Cleaved-PARP, Bim and Cleaved Caspase-9, decreasesd Bcl-2 in a dose- and time-dependent manner. Immunofluorescence [1] Cell Line: MCF-7 Concentration: 25-200 nM Incubation Time: 8 h Result: Disrupted the microtubule network into punctate. |
體內(nèi)活性 | 抗腫瘤劑-138 (20 mg/kg,腹腔注射,21天) 在MCF-7異種移植BALB/c裸鼠模型中表現(xiàn)出68.95%的腫瘤生長(zhǎng)抑制率 [1]。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢價(jià) |
VIP3年
|
陜西締都醫(yī)藥化工有限公司
|
2024-12-18 | |
¥100 |
煙臺(tái)恒諾新材料有限公司
|
2024-12-13 |